Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Common Stock Authorized (Details)

v3.22.4
Stockholders' Equity - Common Stock Authorized (Details) - USD ($)
 9 Months Ended 12 Months Ended
Dec. 31, 2022
Mar. 31, 2022
Stockholders' Equity    
Balance beginning of period $ 2,927,212  
Shares issued for in lieu of services (in shares)   50,000
Balance at end of period $ (521,906) $ 2,927,212
Common Shares and Exchangeable Shares    
Stockholders' Equity    
Balance beginning of period (in shares) 6,879,554  
Balance beginning of period $ 6,879  
Balance at end of period (in shares) 6,879,554 6,879,554
Balance at end of period $ 6,879 $ 6,879
Exchangeable Shares    
Stockholders' Equity    
Balance beginning of period (in shares) 112,440 112,440
Balance beginning of period $ 113 $ 113
Converted into common shares (in shares) (1,048) 0
Converted into common shares $ (1) $ 0
Balance at end of period (in shares) 111,392 112,440
Balance at end of period $ 112 $ 113
Common Shares    
Stockholders' Equity    
Balance beginning of period (in shares) 6,767,114 5,589,375
Balance beginning of period $ 6,766 $ 5,589
Shares issued on conversion of loans (in shares)   947,602
Shares issued on conversion of loans   $ 947
Shares issued for in lieu of services (in shares)   50,000
Shares issued for in lieu of services   $ 50
Options exercised in conjunction with 2021 Notes (in shares)   180,137
Options exercised in conjunction with 2021 Notes   $ 180
Exchangeable shares converted into common shares (in shares) 1,048  
Exchangeable shares converted into common shares $ 1  
Balance at end of period (in shares) 6,768,162 6,767,114
Balance at end of period $ 6,767 $ 6,766